Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - bioAffinity Technologies (NASDAQ: BIAF)
Follow
NASDAQ:BIAF
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
officer: President & CEO
04/08/2024
Buy
$1.16
64,848
$75K
229,506
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
officer: President & CEO
04/08/2024
Sell
$2.65
28,264
$75K
201,242
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
officer: President & CEO
04/08/2024
Sell
$1.16
64,848
$75K
0
NASDAQ
BIAF
bioAffinity Technologies
Zannes Timothy P
/
officer: Secretary, EVP, Gen. Counsel
04/04/2024
Buy
$1.16
64,848
$75K
75,155
NASDAQ
BIAF
bioAffinity Technologies
Zannes Timothy P
/
officer: Secretary, EVP, Gen. Counsel
04/04/2024
Sell
$2.58
29,031
$75K
46,124
NASDAQ
BIAF
bioAffinity Technologies
Zannes Timothy P
/
officer: Secretary, EVP, Gen. Counsel
04/04/2024
Sell
$1.16
64,848
$75K
0
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director
04/03/2024
Buy
$1.16
64,848
$75K
1.06M
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director
04/03/2024
Sell
$2.24
33,438
$75K
1.02M
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director
04/03/2024
Sell
$1.16
64,848
$75K
0
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
02/16/2024
Buy
$1.52
39,474
$60K
991,758
NASDAQ
BIAF
bioAffinity Technologies
Anderson Robert A.
/
director
02/26/2024
Buy
$1.16
64,848
$75K
121,856
NASDAQ
BIAF
bioAffinity Technologies
Anderson Robert A.
/
director
02/26/2024
Sell
$1.12
64,848
$72K
0
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
01/01/2024
Buy
$1.48
12,668
$19K
940,341
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
10/01/2023
Buy
$1.58
11,867
$19K
927,673
NASDAQ
BIAF
bioAffinity Technologies
KNIGHT PETER S
/
director
01/01/2024
Buy
$1.48
12,668
$19K
75,375
NASDAQ
BIAF
bioAffinity Technologies
KNIGHT PETER S
/
director
10/01/2023
Buy
$1.58
11,867
$19K
62,707
NASDAQ
BIAF
bioAffinity Technologies
Rubin Gary D
/
director, 10 percent owner:
01/01/2024
Buy
$1.48
12,668
$19K
104,517
NASDAQ
BIAF
bioAffinity Technologies
Rubin Gary D
/
director, 10 percent owner:
10/01/2023
Buy
$1.58
11,867
$19K
91,849
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
director, officer: President, CEO
01/01/2024
Buy
$1.48
12,668
$19K
140,773
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
director, officer: President, CEO
10/01/2023
Buy
$1.58
11,867
$19K
128,105
NASDAQ
BIAF
bioAffinity Technologies
DIAMOND STUART
/
director
01/01/2024
Buy
$1.48
12,668
$19K
57,008
NASDAQ
BIAF
bioAffinity Technologies
DIAMOND STUART
/
director
10/01/2023
Buy
$1.58
11,867
$19K
44,340
NASDAQ
BIAF
bioAffinity Technologies
Meghji Mohsin Y
/
director
10/01/2023
Buy
$1.58
11,867
$19K
109,737
NASDAQ
BIAF
bioAffinity Technologies
Anderson Robert A.
/
director
01/01/2024
Buy
$1.48
12,668
$19K
57,008
NASDAQ
BIAF
bioAffinity Technologies
Anderson Robert A.
/
director
10/01/2023
Buy
$1.58
11,867
$19K
44,340
NASDAQ
BIAF
bioAffinity Technologies
Joyce Roby
/
director
01/01/2024
Buy
$1.48
12,668
$19K
24,535
NASDAQ
BIAF
bioAffinity Technologies
Joyce Roby
/
director
10/01/2023
Buy
$1.58
11,867
$19K
11,867
NASDAQ
BIAF
bioAffinity Technologies
Platt Jamie
/
director
01/01/2024
Buy
$1.48
12,668
$19K
12,668
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
08/09/2023
Buy
$2.28
26,315
$60K
915,806
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
07/01/2023
Buy
$1.83
10,245
$19K
889,491
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
04/15/2023
Buy
$1.89
9,920
$19K
879,246
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
01/01/2023
Buy
$2.28
8,227
$19K
869,326
NASDAQ
BIAF
bioAffinity Technologies
DIAMOND STUART
/
director
07/01/2023
Buy
$1.83
10,245
$19K
32,473
NASDAQ
BIAF
bioAffinity Technologies
DIAMOND STUART
/
director
04/15/2023
Buy
$1.89
9,920
$19K
22,228
NASDAQ
BIAF
bioAffinity Technologies
DIAMOND STUART
/
director
01/01/2023
Buy
$2.28
8,227
$19K
12,308
NASDAQ
BIAF
bioAffinity Technologies
Anderson Robert A.
/
director
07/01/2023
Buy
$1.83
10,245
$19K
32,473
NASDAQ
BIAF
bioAffinity Technologies
Anderson Robert A.
/
director
04/15/2023
Buy
$1.89
9,920
$19K
22,228
NASDAQ
BIAF
bioAffinity Technologies
Anderson Robert A.
/
director
01/01/2023
Buy
$2.28
8,227
$19K
12,308
NASDAQ
BIAF
bioAffinity Technologies
Meghji Mohsin Y
/
director
07/01/2023
Buy
$1.83
10,245
$19K
97,870
NASDAQ
BIAF
bioAffinity Technologies
Meghji Mohsin Y
/
director
04/15/2023
Buy
$1.89
9,920
$19K
87,625
NASDAQ
BIAF
bioAffinity Technologies
Meghji Mohsin Y
/
director
01/01/2023
Buy
$2.28
8,227
$19K
77,705
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
07/01/2023
Buy
$1.83
10,245
$19K
889,491
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
04/15/2023
Buy
$1.89
9,920
$19K
879,246
NASDAQ
BIAF
bioAffinity Technologies
GIRGENTI STEVEN
/
director, officer: Executive Chairman
01/01/2023
Buy
$2.28
8,227
$19K
869,326
NASDAQ
BIAF
bioAffinity Technologies
Rubin Gary D
/
director, 10 percent owner:
07/01/2023
Buy
$1.83
10,245
$19K
79,982
NASDAQ
BIAF
bioAffinity Technologies
Rubin Gary D
/
director, 10 percent owner:
04/15/2023
Buy
$1.89
9,920
$19K
69,737
NASDAQ
BIAF
bioAffinity Technologies
Rubin Gary D
/
director, 10 percent owner:
01/01/2023
Buy
$2.28
8,227
$19K
59,817
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
director, officer: President, CEO
07/01/2023
Buy
$1.83
10,245
$19K
116,238
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
director, officer: President, CEO
06/06/2023
Buy
$1.91
26,178
$50K
105,993
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
director, officer: President, CEO
04/15/2023
Buy
$1.89
9,920
$19K
79,815
NASDAQ
BIAF
bioAffinity Technologies
Zannes Maria
/
director, officer: President, CEO
01/01/2023
Buy
$2.28
8,227
$19K
69,895
NASDAQ
BIAF
bioAffinity Technologies
Dougherty Michael Philip
/
officer: Chief Financial Officer
06/06/2023
Buy
$1.91
52,356
$100K
52,356
NASDAQ
BIAF
bioAffinity Technologies
KNIGHT PETER S
/
director
07/01/2023
Buy
$1.83
10,245
$19K
50,840
NASDAQ
BIAF
bioAffinity Technologies
KNIGHT PETER S
/
director
04/15/2023
Buy
$1.89
9,920
$19K
40,595
NASDAQ
BIAF
bioAffinity Technologies
KNIGHT PETER S
/
director
01/01/2023
Buy
$2.28
8,227
$19K
30,675
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Buy
$6.75
14,811
$100K
327,909
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Buy
$4.20
27,378
$115K
313,098
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Buy
$4.20
87,851
$369K
285,720
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Buy
$4.20
31,780
$133K
197,869
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Buy
$6.13
71,428
$437K
71,428
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
07/20/2022
Buy
$5.25
47,935
$252K
47,935
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Buy
$6.13
24,602
$151K
24,602
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Buy
$6.13
23,809
$146K
23,809
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Sell
$4.20
0
$0
0
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Sell
$4.20
0
$0
0
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Sell
$6.75
103,682
$700K
0
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Sell
$4.20
87,851
$369K
0
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
09/06/2022
Sell
$4.20
27,378
$115K
0
NASDAQ
BIAF
bioAffinity Technologies
Perlmutter Nathan M
/
10 percent owner
07/20/2022
Sell
$5.25
47,935
$252K
0
NASDAQ
BIAF
bioAffinity Technologies
Meghji Mohsin Y
/
director
09/06/2022
Buy
$3.67
40,907
$150K
69,478
NASDAQ
BIAF
bioAffinity Technologies
Meghji Mohsin Y
/
director
09/06/2022
Sell
$3.67
286,349
$1.051M
0
NASDAQ
BIAF
bioAffinity Technologies
Meghji Mohsin Y
/
director
08/29/2022
Sell
$7.70
7,142
$55K
0
NASDAQ
BIAF
bioAffinity Technologies
Meghji Mohsin Y
/
director
08/29/2022
Sell
$4.20
7,142
$30K
0
NASDAQ
BIAF
bioAffinity Technologies
Zannes Timothy P
/
officer: Secretary, EVP, Gen. Counsel
08/29/2022
Sell
$7.70
2,142
$16K
0
NASDAQ
BIAF
bioAffinity Technologies
KNIGHT PETER S
/
director
08/29/2022
Sell
$4.20
7,142
$30K
0
NASDAQ
BIAF
bioAffinity Technologies
Anderson Robert A.
/
director
08/29/2022
Sell
$4.20
7,142
$30K
0
NASDAQ
BIAF
bioAffinity Technologies
DIAMOND STUART
/
director
08/29/2022
Sell
$4.20
7,142
$30K
0
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On Twitter
Advertise Your Company
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.